Cell-free DNA (cfDNA) analysis is transforming precision medicine, offering a non-invasive window into the body, particularly in the context of cancer. This journal collection, hosted by npj Precision ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

Cancer is often difficult to detect in its early stages. Biomarkers that can reveal the disease are present only in very small amounts in the blood. As a result, many tests today require additional ...

Earlier detection and diagnosis of cancer holds the greatest potential for transformational improvements in patient outcomes. We’re driving progress in this area and helping establish a sustainable ...

A blood test designed to find cancer early did not work as hoped in a major new study, according to the company that makes it. Adult survivors of childhood cancers are at higher risk for another ...

This important study demonstrates that a peri-nuclear actomyosin network, present in some types of human cells, facilitates kinetochore-spindle attachment of chromosomes in unfavorable locations - ...

$12 million awarded to six collaborative teams developing new approaches to the earlier detection and diagnosis of pancreatic, ovarian, and esophageal cancers These cancers often grow and spread ...

Though still in early stages, some experts say that A.I.-supported screenings could help save patients' health, time and money. praetorianphoto via Getty Images Deaths from breast cancer have ...

The role of sequential PET/CT imaging to predict complete response after definitive chemoradiotherapy for locally advanced squamous cell carcinoma of the anal canal. This is an ASCO Meeting Abstract ...